Antiplatelet Agents: Current Drugs and Future Trends
Antiplatelet drugs in clinical use are discussed in terms of their mechanisms of action and the relevancy of that to the physiology of platelets and the pathophysiology of arterial thrombosis. Current clinical usage is outlined in detail for each drug. Experimental antiplatelet drugs also are discussed.
aHines Veteran's Affairs Hospital, Hines, IL 60141, USA
bLoyola University Stritch School of Medicine, Cancer Center, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA
cLoyola University Stritch School of Medicine, Cardiovascular Institute, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA
dLoyola University Stritch School of Medicine, Department of Physiology, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA
eLoyola University Stritch School of Medicine, Department of Gastroenterology, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA
fLoyola University Stritch School of Medicine, Division of Cardiology, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA
Corresponding author. Hines Veteran's Affairs Hospital, Hines, IL 60141
ABSTRACT